Read Ecraid’s July news already? 📩 Discover the latest research, the SNAP trial results, new publications, expert interviews, our 2025 Annual Report, and upcoming events. 👉🏼 Subscribe to our monthly newsletter: mailchi.mp/ecraid/newsl... #InfectiousDiseases #ClinicalResearch #PandemicPreparedness

Henri van Werkhoven explains that training researchers is not just about teaching methods - it is about helping them directly improve the quality and impact of their own research. Meet the expert: ecraid.eu/news/advanci...

The Ecraid 2025 Annual Report reflects on a year of important milestones, with highlights from our research and education activities. A balanced reflection, celebrating our achievements while sharing what we learned from the challenges we faced. Discover it here: drive.proton.me/u/0/3r3ZZUJd...

#Education is an essential tool for advancing clinical research in ID and AMR. At Ecraid, learning is embedded in a European network, connecting education with research & collaboration. 👉🏽Discover the Ecraid x ESCMID Postgraduate Course in Verona and meet our experts: bit.ly/48jUgdg

Pandemic preparedness begins before a crisis arises. Yazdan Yazdanpanah explains why “ever-warm” research & clinical networks are essential for responding to emerging threats. 🦠 Strong partnerships & ongoing collaboration are helping build a more resilient future. 👉🏽Read how: bit.ly/Expert_Yazdan

Behind every trial result: dedication, commitment & collaboration. The SNAP Trial unites 150+ hospitals in 14+ countries to tackle one of the most serious bloodstream infections. Its impact comes from experts & partnerships driving coordinated, high-impact research for patient care: bit.ly/SNAPTrial

📩 Our latest newsletter is out! Discover: Verona methodology course, ECRAID‑Prime milestone, pandemic preparedness across Europe & contribution to the WHO NAVIS protocol for Hantavirus, STRIDE‑CAP vaccine study, and Ecraid's 2027 Science Meeting. 👉🏽Stay informed—subscribe now: bit.ly/news-june-26

💡 New publication - scientific correspondence in BMC Critical Care on #VAP epidemiology! The complete scientific dialogue - including the original manuscript, peer commentary, and authors' response - is available here 🔗 bit.ly/4w2xkZA #ClinicalEpidemiology #InfectiousDiseases #VAP #STATNet

Save the Date: Ecraid Foundation Science Meeting 2027, Verona (2–3 Feb). Join Europe’s infectious diseases & AMR community. Partners from academia, healthcare, industry, and public health will share insights, collaborate, and shape future research. Details to follow. For info: events@ecraid.eu

📣 Practice-changing data published in both the NEJM and The Lancet! The #SNAPTrial results are set to redefine international guidelines for treating golden #Staph bloodstream infections. Ecraid is proud to be a European partner for this landmark study. #PatientSafety #AdaptiveTrials #StaphAureus

Doherty Institute@thedohertyinst.bsky.social · 2mo ago

A landmark international clinical trial (SNAP Trial) has identified the optimal antibiotics for golden staph bloodstream infections, a breakthrough that is set to reshape treatment for the life-threatening condition. https://bit.ly/44eY8Kg

Effective outbreak response depends on networks built in peacetime. Ecraid CEO @lenniederde.bsky.social highlights that pandemic readiness comes from sustained collaboration. Strong partnerships, like BeReady, enable rapid, coordinated public health action. Check interview: bit.ly/ecraidpandem...

We're proud to have contributed to this framework, which is demonstrating its vital role in the coordinated global research response to the AHV outbreak. Embedding high-quality observational research directly into emergency operations is a significant step forward. Learn more bit.ly/4a2MtSh

Twenty-one countries launch coordinated Andes virus research initiative following hantavirus outbreak

Following the recent Andes virus (ANDV) outbreak linked to the MV Hondius cruise ship, a globally coordinated outbreak research initiative involving investigators and institutions across 21 countries ...

bit.ly

The 3-day postgraduate course is designed for researchers using epidemiological and statistical methods, and bridges advanced theory with hands-on project mentorship. Why Attend? 👇🏻 📋 Cutting-edge Curriculum 📝 Publishing Excellence 👩🏻‍🏫 Bespoke Workshops www.escmid.org/event-detail...

Ecraid and @esicm.bsky.social are strengthening collaboration to advance intensive care research, education, & pandemic preparedness across Europe. CEO @lenniederde.bsky.social supports Surviving Sepsis Campaign updates & joins ESICM’s webinar on patient perspectives. Click on the link to attend 👇🏽

European Society of Intensive Care Medicine@esicm.bsky.social · 2mo ago

🎥 Join today’s #ESICMWebinar! Finish the 2026 SSC Guidelines journey with the fourth episode of the dedicated webinar series, and discover how patient & family voices shaped patient-centred sepsis care. 🗓️ 𝗧𝗼𝗱𝗮𝘆, 𝟭𝟲:𝟬𝟬 𝗖𝗘𝗦𝗧 👉 lives-stream.esicm.org/en/catalog/w... #ESICM #Sepsis #IntensiveCare

Happy to share two recent Ecraid publications from our colleagues - congratulations! Risk score for VAP: www.sciencedirect.com/science/arti... Pneumococcal vaccines: publications.ersnet.org/content/erjo... For an overview of Ecraid publications visit our Resources page: ecraid.eu/driving-prog...

🦠Pandemic preparedness isn't built during a crisis but in the quiet periods in between. Preparedness requires a warm-base network that is already connected. This is exactly what Ecraid maintains. 👉🏽Connect with the experts behind it: bit.ly/Ecraid-Connect #PandemicPreparedness #ClinicalTrials

📩Our May Newsletter is out! Discover updates on the new ECRAID Clinical Liaison Council Chair and Vice-Chair, key ECRAID-Prime trial milestones, recent publications, and upcoming courses! 🔍Read more: bit.ly/may26ecraid 👉🏽Subscribe to stay informed each month! #InfectiousDiseases #ClinicalResearch

The ECRAID-Prime #adaptiveplatformtrial is a first-of-its-kind multinational study in community care using decentralised trial elements. Read the key learnings & experiences on meaningful #patientinvolvement to strengthen clinical trials in #publichealth emergencies. 👉🏼 www.ecraid.eu/news/ecraid-...

Ecraid and @esicm.bsky.social announce a strategic partnership to strengthen #ICU research, education, & pandemic preparedness across Europe. Together we’ll expand networks, drive joint studies, co-develop training on infections, sepsis, AMR & crisis preparedness. 👉🏽More info: bit.ly/esicm-ecraid

Today on #KangarooCareAwarenessDay 🦘, we’re proud to support @pentafoundation.bsky.social in raising awareness of kangaroo care. Ecraid is proud to contribute to the #NeoDeco study, exploring how optimised kangaroo care may help reduce #NeonatalInfections and #Sepsis in preterm infants in #NICUs. 🩺

Penta - Child Health Research@pentafoundation.bsky.social · 3mo ago

Tomorrow is #KangarooCareAwarenessDay & #NeoIPC is proud to share 2 new stories in our “NICU Journeys” series, featuring interviews with Emma & Luken's parents 💜🦘 Their experiences highlight the importance of #KangarooCare, family involvement and #IPC in the #NICU. 🎥 Watch here ➡️ lnkd.in/d-sstx5y

Emerging threats like #Hantavirus require a warm-based, unified response. Ecraid works at the heart of the #BEREADY partnership to connect clinical sites with global stakeholders and national authorities. Together with our partners, we stand ready. #PandemicPreparedness #InfectiousDiseases

🙌🏽 Pleased to share that the #ECRAIDPrime LTX-109 study has achieved its recruitment target! 🧪Read more about this EU-funded trial and Phase 2A study on the LTX-109 compound, developed by Pharma Holdings on lnkd.in/eHR28vr9.

Join this 5th edition of our postgraduate course 👉 bit.ly/48jUgdg The programme is not limited to ID specialists; we welcome clinical researchers from all disciplines, epidemiologists, and public health professionals seeking to elevate their study design and evidence generation skills.

Our April newsletter is live! 🔬 Highlights from ESCMID Global 2026 🎓 PG course in Verona now open for registration 🤝🏽 New global partnerships driving innovation in clinical research Stay informed—subscribe for monthly updates: bit.ly/EcraidNewsAp... #InfectiousDiseases #ClinicalResearch #Education

We were pleased to host a successful #SNAPTrial Investigator Meeting at #ESCMIDGlobal2026. Last Tuesday’s session brought together Chief Investigators from across Europe, as well as our Coordinating Chief Investigators from Australia, who provided a valuable global perspective & progress updates.

Wrapping up day 1 at #ESCMIDGlobal2026 not a full stop, just a comma. Great discussions with colleagues & partners, all focused on advancing #InfectiousDiseases research & preparedness. Thanks to everyone who joined our sessions & stopped by. Strong start, round two tomorrow! See you at booth F21!

🌟 #Milestone - The #ECRAIDPrime NONS and saline nasal spray study has concluded, marking the completion of a key phase in evaluating treatments for #respiratoryinfections in the community, and proof-of-concept for accelerating clinical research response to outbreaks. 👉🏼 ecraid.eu/news/ecraid-...

ECRAID-Prime Reaches Milestone as NONS & Saline Study Concludes | Ecraid

ecraid.eu

Last Call to register! 🔔 Join the PrIMAVeRa Stakeholder Meeting & Live hashtag#AMR Dashboard Demo in Munich! 📅 Sunday, 19 April 2026 🕛 12:00 – 15:00 (CEST) 📍 H4 Hotel München Messe (5 mins’ walk from ESCMID venue) Limited spots available! 📩 Interested? Send an email to events@ecraid.eu.

Ecraid has joined the BEAM Alliance, reinforcing our commitment to tackling antimicrobial resistance. By contributing our clinical research expertise and network, we aim to better connect innovation with real-world needs & help shape future AMR solutions in Europe. 👉🏽Read more: bit.ly/BeamAlliance

📣 Arjan van Manen joins us as Head of Business Development. With 20+ years in clinical strategy, he’s focused on closing the gap between clinical need & investment risk. 🤝🏽 Understanding challenges to deliver data-driven, tailored solutions. 📍At ESCMID? Connect with him! 🔗https://bit.ly/ArjanEcraid